Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 4 |
2020 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer.
Biomolecules. 2023 Jan 12;13(1):159. doi: 10.3390/biom13010159.
Biomolecules. 2023.
PMID: 36671544
Free PMC article.
Review.
Advances in delivery vectors for gene therapy in liver cancer.
Redd Bowman KE, Lu P, Vander Mause ER, Lim CS.
Redd Bowman KE, et al.
Ther Deliv. 2020 Jan;11(1):833-850. doi: 10.4155/tde-2019-0076. Epub 2019 Dec 16.
Ther Deliv. 2020.
PMID: 31840560
Review.
Item in Clipboard
p53-Bad* in a Hepatocellular Carcinoma Mouse Model.
Bowman KR, Lu P, Lim C.
Bowman KR, et al.
bioRxiv [Preprint]. 2023 Jun 29:2023.06.29.547129. doi: 10.1101/2023.06.29.547129.
bioRxiv. 2023.
PMID: 37425886
Free PMC article.
Preprint.
Item in Clipboard
p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy.
Lu P, Redd Bowman KE, Brown SM, Joklik-Mcleod M, Vander Mause ER, Nguyen HTN, Lim CS.
Lu P, et al. Among authors: redd bowman ke.
Mol Pharm. 2019 Aug 5;16(8):3386-3398. doi: 10.1021/acs.molpharmaceut.9b00136. Epub 2019 Jun 26.
Mol Pharm. 2019.
PMID: 31241338
Free PMC article.
Item in Clipboard
Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer.
Bowman KR, Kim JH, Lim CS.
Bowman KR, et al.
J Ovarian Res. 2019 Apr 30;12(1):38. doi: 10.1186/s13048-019-0514-4.
J Ovarian Res. 2019.
PMID: 31039796
Free PMC article.
Item in Clipboard
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53.
Lu P, Vander Mause ER, Redd Bowman KE, Brown SM, Ahne L, Lim CS.
Lu P, et al. Among authors: redd bowman ke.
J Ovarian Res. 2019 May 15;12(1):45. doi: 10.1186/s13048-019-0516-2.
J Ovarian Res. 2019.
PMID: 31092272
Free PMC article.
Item in Clipboard
Cite
Cite